Background: In the recent Pathway CH-1 study, on-demand stimulation of the sphenopalatine ganglion (SPG) by means of an implantable neurostimulation system was proven to be a safe and effective therapy for the treatment of chronic cluster headache. Our objective was to assess the cost-effectiveness of SPG stimulation in the German healthcare system when compared to medical management.

Methods: Clinical data from the Pathway CH-1 study were used as input for a model-based projection of the cost-effectiveness of SPG stimulation through 5 years. Medical management as the comparator treatment was modeled on the basis of clinical events observed during the baseline period of CH-1. The costs of treatment were derived from a previously published cluster headache costing study and 2014 medication, neurostimulator, and procedure costs. We computed the 5-year incremental cost-effectiveness ratio (ICER) in euros per quality-adjusted life year (QALY), with costs and effects discounted at 3 % per year.

Results: SPG stimulation was projected to add 0.325 QALYs over the study period, while adding €889 in cost, resulting in a 5-year ICER of €2,736 per QALY gained. Longer follow-up periods, higher baseline attack frequency, and higher utilization of attack-aborting medications led to overall cost savings. SPG stimulation was found either cost-effective or cost-saving across all scenarios investigated in sensitivity analyses.

Conclusions: Our model-based analysis suggests that SPG stimulation for the treatment of chronic cluster headache, under the assumption of sustained therapy effectiveness, leads to meaningful gains in health-related quality of life and is a cost-effective treatment strategy in the German healthcare system.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441877PMC
http://dx.doi.org/10.1186/s10194-015-0530-8DOI Listing

Publication Analysis

Top Keywords

spg stimulation
20
cluster headache
16
treatment chronic
12
chronic cluster
12
pathway ch-1
12
ch-1 study
12
stimulation sphenopalatine
8
sphenopalatine ganglion
8
ganglion spg
8
model-based analysis
8

Similar Publications

Sphenopalatine ganglion stimulation for the treatment of cerebrovascular ischemia.

Clin Auton Res

December 2024

Facultad de Medicina, Universidad Autónoma de Sinaloa, C. Sauces, s/n, 80019, Culiacán, SIN, Mexico.

Purpose: The parasympathetic effects of the sphenopalatine ganglion (SPG) on the cerebral vasculature provide a compelling rationale for its therapeutic application in cerebrovascular ischemia. In recent years, attempts have been made to stimulate the SPG to achieve beneficial effects on cerebral circulation.

Methods: This review synthesizes the available publications on SPG stimulation.

View Article and Find Full Text PDF
Article Synopsis
  • * It is created by polymerizing AMB monomer with gelatin, crosslinking it, and embedding strontium titanate nanoparticles, resulting in a hydrogel with strong tissue adhesion and the ability to generate voltage and current through mechanical motion.
  • * In trials with mice, the SPG hydrogel significantly expedited the healing process, reducing wound size and improving skin quality, indicating its potential as an innovative tool for electrotherapy in wound care.
View Article and Find Full Text PDF

Scope: Cordyceps cicadae polysaccharides have received attention due to their potential in treating hyperglycemia and enhancing renal function. The beneficial effect of the purified C. cicadae polysaccharides fraction (CCP-1) on the reproductive impairments and spermatogenesis dysfunction of immunocompromised mice is unavailable and is studied herein.

View Article and Find Full Text PDF

The January 2022 eruption of the Hunga Tonga-Hunga Ha'apai (HTHH) volcano discharged 2,900 teragrams of ejecta, most of which was deposited in the South Pacific Ocean. Here we investigate its impact on the biogeochemistry of the South Pacific Gyre (SPG) using samples collected during the GEOTRACES cruise GP21 in February-April 2022. Surface water neodymium isotopes and rare earth element compositions showed a marked volcanic impact in the western SPG, potentially extending to the eastern region.

View Article and Find Full Text PDF

Obstructive sleep apnea (OSA) is a prevalent sleep-related breathing disorder that results in multiple bouts of intermittent hypoxia. OSA has many neurological and systemic comorbidities, including dysphagia, or disordered swallow, and discoordination with breathing. However, the mechanism in which chronic intermittent hypoxia (CIH) causes dysphagia is unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!